Hedgehog signaling pathway

Hedgehog signaling pathway
Name	Hedgehog signaling pathway
Involved genes	SHH, IHH, DHH, PTCH1, SMO, GLI1, GLI2, GLI3, SUFU
Species	Drosophila melanogaster, Mus musculus, Homo sapiens
Diseases	Basal cell carcinoma, Medulloblastoma, Gorlin syndrome

Hedgehog signaling pathway. The Hedgehog signaling pathway is a crucial cell communication system essential for embryonic development and tissue maintenance. Its discovery in Drosophila melanogaster by Christiane Nüsslein-Volhard and Eric Wieschaus, for which they received the Nobel Prize in Physiology or Medicine, revealed fundamental principles of morphogen-gradient formation. Dysregulation of this pathway is implicated in numerous congenital malformations and cancers, making it a major target for therapeutic development.

Overview

The pathway is named for the *Drosophila* *hedgehog* gene, where mutant larvae exhibit a spiky phenotype. In vertebrates, three homologous ligands exist: Sonic hedgehog (SHH), Indian hedgehog (IHH), and Desert hedgehog (DHH). These secreted proteins act as morphogens to pattern structures like the neural tube, limb buds, and somites. The core transduction machinery involves the receptor Patched (PTCH1), the signal transducer Smoothened (SMO), and the GLI family of transcription factors, whose activity is regulated by the suppressor SUFU.

Mechanism of action

In the absence of a Hedgehog ligand, PTCH1 localizes to the primary cilium and inhibits SMO, preventing its ciliary accumulation. This allows the protein kinase A (PKA), GSK3β, and CK1 to phosphorylate full-length GLI proteins, targeting them for proteasomal processing into repressor forms. Binding of a Hedgehog ligand to PTCH1 relieves its inhibition of SMO, enabling SMO to enter the cilium and initiate a cascade that blocks GLI phosphorylation. This leads to the nuclear translocation of full-length GLI activators, which regulate target genes such as PTCH1 itself, GLI1, and CCND1.

Biological functions

During embryogenesis, the pathway directs the patterning of the central nervous system, notably establishing floor plate identity and motor neuron subtypes in the spinal cord. It is critical for limb development, determining anterior-posterior digit identity. In postnatal life, it regulates stem cell populations in tissues like the skin, brain, and gastrointestinal tract, maintaining homeostasis and enabling regeneration. The pathway also plays roles in bone formation, tooth morphogenesis, and hair follicle cycling.

Role in disease

Germline mutations in pathway components cause developmental disorders such as holoprosencephaly (often linked to SHH mutations) and Gorlin syndrome (caused by PTCH1 mutations). Constitutive activation of the pathway is a driver in several cancers, most notably Basal cell carcinoma and Medulloblastoma. Aberrant signaling is also found in rhabdomyosarcoma, pancreatic adenocarcinoma, and leukemias. Furthermore, pathway dysregulation contributes to fibrotic diseases and certain neurodegenerative conditions.

Evolutionary conservation

The Hedgehog pathway is highly conserved across the Bilateria. Key components like Hedgehog, Patched, and Smoothened have orthologs in *Drosophila*, *C. elegans*, and all studied vertebrates. The use of the primary cilium as a signaling hub is a vertebrate adaptation, though some intraflagellar transport proteins involved are conserved in *Chlamydomonas*. Studies in organisms like the zebrafish and the chicken have been instrumental in elucidating its roles in chordate development.

Pharmacological targeting

The first clinically approved Hedgehog pathway inhibitor was Vismodegib, a SMO antagonist developed by Genentech for treating metastatic Basal cell carcinoma. Other SMO inhibitors include Sonidegib and Glasdegib, the latter used for acute myeloid leukemia. Resistance mechanisms often involve mutations in SMO or amplification of downstream GLI factors, spurring research into direct GLI inhibitors and compounds targeting upstream regulators. These agents are being investigated in clinical trials for various solid tumors and hematological malignancies.

Category:Cell signaling Category:Developmental biology Category:Oncology